Divisas / KRYS
KRYS: Krystal Biotech Inc
153.22
USD
0.07
(0.05%)
El tipo de cambio de KRYS de hoy ha cambiado un 0.05%. En este caso, el precio mínimo en el mercado ha alcanzado 151.92, mientras que el máximo ha alcanzado 156.18.
Siga la dinámica de la pareja de divisas Krystal Biotech Inc. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
KRYS News
- Zacks Tango Therapeutics, Inc. (TNGX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Zacks Krystal Biotech, Inc. (KRYS) to Report Q2 Results: Wall Street Expects Earnings Growth
- Investing Jeune Aesthetics reports positive results for skin wrinkle treatment
- Investing Insider Activity Recap: Wednesday’s Top Buys and Sells Revealed
- Investing Krystal biotech (KRYS) director Suma Krishnan sells $5.39m in stock
- Investing Krishnan Krish S, Krystal Biotech CEO, sells $5.39 million in stock
- Investing Krystal Biotech stock maintains Buy rating as first patient dosed in NK trial
- Investing Citi raises Krystal Biotech stock price target to $176 on KB801 trial progress
- Investing Krystal Biotech begins phase 1/2 trial of eye drop gene therapy for NK
- Investing Clear Street initiates Krystal Biotech stock with Buy rating, $190 target
- Investing H.C. Wainwright reiterates Buy rating on Krystal Biotech stock ahead of Q2 results
- The Motley Fool 10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
- Investing Krystal Biotech stock maintains buy rating as phase 3 eye drop study begins
- Investing Krystal Biotech Announces First Patient Dosed in Phase 3 Clinical Trial of KB803 for the Treatment and Prevention of Corneal Abrasions in Patients with Dystrophic Epidermolysis Bullosa
- Seeking Alpha Abeona Therapeutics' Zevaskyn Vs. Krystal Biotech's Vyjuvek (KRYS, ABEO)
- Investing Krystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare Conference
- Investing H.C. Wainwright maintains Krystal Biotech stock Buy rating at ASCO 2025
- Investing Krystal Biotech stock hits 52-week low at $127.33
- Benzinga Abeona Surges After FDA Clears First Gene Therapy For Severe Genetic Skin Disease - Abeona Therapeutics (NASDAQ:ABEO)
- Seeking Alpha Abeona: pz-cel Has Massive Potential For RDEB Patients (NASDAQ:ABEO)
- Seeking Alpha Abeona Stock: A Buy With Major PDUFA Catalyst On April 29 That Should Send Shares Higher
- Seeking Alpha Krystal Biotech: Some Uncertainty, Some Value (NASDAQ:KRYS)
- Seeking Alpha Krystal Biotech: Preparing To Chase Following Positive CHMP Opinion For VYJUVEK
- Investor Place 3 Stocks to Sell on an Escalating Trade War
Rango diario
151.92
156.18
Rango anual
123.03
209.07
- Cierres anteriores
- 152.08
- Open
- 153.15
- Bid
- 153.22
- Ask
- 153.52
- Low
- 151.92
- High
- 156.18
- Volumen
- 636
- Cambio diario
- 0.05%
- Cambio mensual
- 10.66%
- Cambio a 6 meses
- -2.84%
- Cambio anual
- -26.71%
31 julio, jueves
11:30
USD
- Act.
- Pronós.
- Prev.
- 47.999 K
11:30
USD
- Act.
- Pronós.
- -68.3%
- Prev.
- -1.6%
12:30
USD
- Act.
- Pronós.
- 0.4%
- Prev.
- 0.2%
12:30
USD
- Act.
- Pronós.
- 2.6%
- Prev.
- 2.7%
12:30
USD
- Act.
- Pronós.
- 0.2%
- Prev.
- 0.1%
12:30
USD
- Act.
- Pronós.
- 2.3%
- Prev.
- 2.3%
12:30
USD
- Act.
- Pronós.
- 0.2%
- Prev.
- -0.1%
12:30
USD
- Act.
- Pronós.
- 0.7%
- Prev.
- -0.4%
12:30
USD
- Act.
- Pronós.
- 0.0%
- Prev.
- -0.3%
12:30
USD
- Act.
- Pronós.
- 0.9%
- Prev.
- 0.9%
12:30
USD
- Act.
- Pronós.
- 1.0%
- Prev.
- 1.2%
12:30
USD
- Act.
- Pronós.
- 0.7%
- Prev.
- 0.8%
12:30
USD
- Act.
- Pronós.
- 224 K
- Prev.
- 217 K
12:30
USD
- Act.
- Pronós.
- 1.966 M
- Prev.
- 1.955 M
12:30
USD
- Act.
- Pronós.
- 222.299 K
- Prev.
- 224.500 K
13:45
USD
- Act.
- Pronós.
- 42.4
- Prev.
- 40.4
14:00
USD
- Act.
- Pronós.
- 2.3%
- Prev.
- 2.0%
14:30
USD
- Act.
- Pronós.
- 2 B
- Prev.
- 23 B
15:30
USD
- Act.
- Pronós.
- Prev.
- 4.245%
15:30
USD
- Act.
- Pronós.
- Prev.
- 4.265%